GTR 74152900
Bids Are Invited For Acquisition Of Special Medicines For Healthcare Assistance.
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
74152900
Tendering Authority
Subscribe to view
Tender No
00009/2023
Financer Name
Self-Funded
Work Title
Bids Are Invited For Acquisition Of Special Medicines For Healthcare Assistance.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
04-01-2024
Closed
Work Detail
Abatacept, Abiraterone Acetate, Ursodeoxycholic Acid, Zoledronic Acid, Adalimumab, Aflibercept, Pancreatic Enzymes, Anagrelide Hydrochloride, Aripiprazole, Azacitidine, Belimumab, Bicalutamide, Cabergoline, Capecitabine, Ferric Carboxymaltose, Certolizumab Pegol, Cyclosporine, Chlorambucil, Clozapine, Dasatinib E, Deferasirox, Degarelix , Denosumab, Desmopressin Acetate, Eltrombopag Olamine, Enoxaparin, Enzalutamide, Epoetin Alfa, Erlotinib, Spiramycin, Etanercept, Exemestane, Filgrastim, Fulvestrant, Golimumab, Goserelin Acetate, Sodium Hyaluronate, Hylan, Ibrutinib, Imatinib Mesylate, Human Immunoglobulin, Infliximab, In Southern, Lapatinib, Leflunomide, Letrozole, Leuprorelin Acetate, Levonorgestrel, Liraglutide, Megestrol Acetate, Melphalan, Mercaptopurine, Methylphenidate Hydrochloride, Methotrexate, Nilotinib, Nintedanib, Octreotide, Olanzapine, Omalizumab, Oxycodone Hydrochloride, Paliperidone, Palivizumab, Pazopanib, Plerixafor, Pramipexole, Pregabalin, Quetiapine, Ranibizumab, Riluzole, Rivastigmine, Ruxolitinib, Sildenafil, Somatropin, Sorafenib Tosylate, Sunitinib, Temozolomide, Teriparatide, Testosterone, Thioguanine, Tiotropium Bromide, Tofacitinib, Botulinum Toxin, Tretinoin, Arsenic Trioxide, Ustekinumab, Vemurafenib, Vinorelbine, Abema Ciclibe, Apalutamide , Medicinal Extract, Ocrelizumab, Palbociclib, Risankizumab, Secukinumab, Tocilizumab, Durvalumab, Bevacizumab, Pemetrexed, Atezolizumab, Pembrolizumab, Irinotecan Hydrochloride, Pertuzumab, Ramucirumab, Rituximab, Trastuzumab, Carboplatin, Cyclophosphamide, Docetaxel, Doxorrub Icin Hydrochloride, Doxorubicin Hydrochloride, Fluorouracil, Oxaliplatin , Paclitaxel, Vincristine, Alectinib, Darolutamide, Osimertinib
Key Value
Tender Value
29,515,284 - BRL
Tender Documents
Global Tender Document
f69f61a5-b392-4310-97fb-f089c17cf093.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.